The 53rd Annual Meeting- 2012

Switzerland and Northern Italy May 3-May 13, 2012.

The North American Clinical Dermatologic Society hosts an educational program with sessions that feature a variety of important topics for the practicing dermatologists. Sessions will cover the latest update on procedural and medical dermatology with a focus on how this information can be used in an everyday dermatology practice. Other sessions include the latest conventional therapies and use of biologics for the treatment of psoriasis, the diagnosis and treatment of CTCL and frontal fibrosing alopecia surgical techniques in ophthalmologic procedures and how they relate to dermatology. Excisional surgery with innovative reconstructive repairs for the general dermatologists will be presented and other topics of interest to individual dermatologists will be discussed comparing how dermatologists diagnose and treat patients with similar diagnoses in the United States and in other countries. An in depth presentation analyzing the economic consequences of the healthcare reform bill will also be given.

WHO SHOULD ATTEND

The target audience is the practicing dermatologist and dermatology residents who are interested in updated general medical and procedural dermatology.

COURSE OBJECTIVES

• Upon completion of this program participants should be able to:

• Identify, compare and contrast Dermatology as it is practiced in the United States and in other countries as it relates to commonly occurring dermatologic disease such as psoriasis, eczema and skin carcinoma.

• Identify and distinguish the unique aspects of procedural dermatology that relate to the everyday practice in the United States. At the end of this activity the physician should be able to integrate this information for use in the everyday practice of dermatology in the United States.

• Understand and apply information from the review of medical literature to every day practice as it relates to dermatology. The participant should be able to assess and interpret new information from non-dermatologic literature and translate this information as it applies to common dermatologic diseases.

• Assess patient needs for the use of new biologic agents for dermatologic disease. Evaluate patient needs and requirements for biologic agents and properly use the agents appropriately for a given disorder in individual patients.

• Recall and apply information from other specialties e.g. ophthalmology and pathology as it relates to dermatology.

ACCREDITATION

This activity has been planned and implemented in accordance with the essential areas and polices of the Accreditation Council for Continuing Medical Education through the joint sponsorship of MedChi, The Maryland State Medical Society and The North American Clinical Dermatologic Society. MedChi is accredited by the ACCME to provide continuing medical education for physicians. MedChi designates this activity for a maximum of 9 AMA PRA Category 1 credits. Physicians should only claim credit commensurate with the extent of their participation in the activity.

CREDIT DESIGNATION

The North American Clinical Dermatologic Society‘s Annual Meeting is recognized by the American Academy of Dermatology for ____Category 1 CME Credits and may be used toward the American Academy of Dermatology’s Continuing Medical Education Award. AAD Program # 279100.

DISCLOSURE AND CONFLICT OF INTEREST RESOLUTION

All conflicts of interest of any individual(s) in a position to control the content of this CME activity will be indentified and resolved prior to this educational activity being provided. Disclosure about provider and faculty relationships, or the lack thereof, will be provided to learners.